FAQ


  • Clariant shares are traded at virt-x, the home market for the Swiss Market Index (SMI) stocks.
  • The stock symbol for Clariant shares is CLN.
  • Clariant’s Initial Public Offer was in 1995.
  • Based on the notifications received by Clariant and published by SIX Exchange Regulation, as at 31 December 2016 the following shareholders held more than 3% of voting rights in Clariant:

     Shareholders Voting rights
     Group of former shareholders of Süd-Chemie AG1  13.89 %
    Thereof (as a separate sub-group): Blue Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany) and Maple Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany) 2   3.73 %
    APG Asset Management N.V., Amsterdam, Netherlands 5.01 %
    BlackRock Inc., New York 3.08 %
    Cymbria, Canada
    EdgePoint Global Portfolio, Canada
    EdgePoint Canadian Growth and Income Portfolio, Canada
    EdgePoint Canadian Portfolio, Canada
    EdgePoint Global Growth and Income Portfolio, Canada
    St. James Place Global Equity Unit Trust, UK
       3.06 %
    Citadel Multi-Strategy Equities Sàrl
    Citadel Global Equities Fund Sàrl
    Citadel Securities (Europe) Limited
       3.02 %
    Norges Bank (the Central Bank of Norway) 3.003 %
    UBS Funds Management (Switzerland) AG 3.001 %
    1 The following former shareholders of Süd-Chemie AG form a group:
    Wilhelm, Dr. Winterstein, Germany
    Dolf, Dr. Stockhausen, Switzerland
    Axel, Dr. Schweighart, Germany
    Rosemarie Schweighart, Germany
    Dominique Kraus, Germany
    Karl, Dr. Wamsler, Germany
    Irene W. Banning, United States
    Susanne Wamsler-Singer, Austria
    Caroline A., Dr. Wamsler, United States
    Amelie Ratjen, Germany
    Christof Ratjen, Germany
    Christopher Weithauer, Germany
    Johanna Bechtle, Germany
    Kaspar Bechtle, Germany
    Luisa Redetzki, Germany
    Karl T. Banning, United States
    Schuyler H. Joerger, United States
    Konstantin Alfred Winterstein, Germany
    Max-Theodor, Dr. Schweighart, Germany
    Peter, Dr. Schweighart, Germany
    Moritz Ostenrieder, Germany
    Christian Ratjen, Germany
    Bettina Wamsler, Germany
    Pauline Joerger, United States
    Marianne Kunisch, Germany
    Maximilian Ratjen, Germany
    Julius Ratjen, Germany
    Elisabeth Prinzessin zu Sayn-Wittgenstein, Germany
    Georg A. Weithauer, Germany
    Charlotte Bechtle, Germany
    Clara Redetzki, Germany
    Marie Redetzki, Germany
    Sophia P. Joerger, United States
    2According to a disclosure notification published on 18 January 2013, a group consisting of Konstantin Winterstein, 80333 München, Germany and Elisabeth Prinzessin zu Sayn-Wittgenstein, 80333 München, Germany holds 3.73% partially through Blue Beteiligungsgesellschaft mbH, Grossdingharting (Germany) and partially through Maple Beteiligungsgesellschaft mbH, Grossdingharting (Germany). The 3.73% held by this group are included in the 13.89% mentioned under footnote 1, but build a separate sub-group.
               

    Disclosure notifications during the financial year 2014 notified to the Stock Exchange Disclosure Office pursuant to Art. 20 of the Stock Exchange Act can be found on the SIX Swiss Exchange reporting platform: http://www.six-exchange-regulation.com/obligations/disclosure/major_shareholders_de.html

  • As of 31 December 2016, the fully paid nominal share capital of Clariant Ltd totaled CHF 1 288 175 036.30 and was divided into 331 939 199 registered shares, each with a par value of CHF 3.70. Clariant Ltd shares have been listed on the SIX Swiss Exchange since 1995 (symbol: CLN, ISIN CH0012142631). Clariant Ltd does not issue non-voting equity securities (Genussscheine).

  • Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. Our business units are divided into six market segments: Consumer Care, Industrial Applications, Plastics & Coatings, Energy, Resources, and Bio Tech.
  • Clariant is divided into seven Business Units. The Business Units have operational autonomy within the overall group strategy, and are entirely responsible for their own business success. Clariant’s business units are divided into four Business Areas: Care Chemicals, Catalysis, Natural Rescources and Plastics & Coatings.



  • Clariant has a strong heritage going back to the 1850s with roots in both Sandoz and Hoechst Specialty Chemicals. In 1995, Clariant was established by demerger from Sandoz Chemicals Division. In 1997, Clariant bought Hoechst Speciality Chemicals and in 2011, Clariant acquired Süd-Chemie.

  • Roughly 17 440 employees in more than 100 group companies on five continents generate annual sales of around CHF 5 847 m (full year 2016 reported figures from continuing operations).



  • You won't find the name of our company on products in a department store. But some of our brands have been well-known for years in the marketplace. Just follow the links in the Key Business Facts section of this website to access the corresponding websites or search by trade names.

  • Clariant’s main strengths are expertise, applications experience and market knowledge combined continually in creative ways. Clariant is committed to sustainable growth springing from its own innovative strength.

Datei herunterladen

Bitte geben Sie Ihre Kontaktdaten ein. Die Datei wird nach der Übermittlung Ihrer Daten sofort automatisch heruntergeladen. Dies ist nur für die erste Datei erforderlich, die Sie auf dieser Seite herunterladen. Vielen Dank für Ihr Verständnis.

Persönliche Informationen

Ihr Name*

 

Ihre E-Mail-Adresse*

Ihre Position

Ihr Unternehmen

  • At Clariant, R&D is a key driver to generate profitable growth. Four Technology Platforms are the basis to develop innovative products for today’s and tomorrow’s markets: Chemistry & Materials, Biotechnology, Catalysis and Process Technology. Clariant’s R&D Centers are shaped along these Technology Platforms and are connected with the world-wide network of Technical Centers of our Business Units to combine technology and application know-how to quickly respond to customer needs. About 6 500 patents safeguard our knowledge about products and methods. In 2016, the Group spent CHF 206 million on R&D, or about 3.5% of sales. Clariant employs approximately 1 100 people in R&D, primarily in Germany, North America, China, and India. The new Clariant Innovation Center (CIC) located in Frankfurt is Clariant’s global flagship for R&D centrally steered via Clariant International Ltd. in Switzerland.



  • Clariant is committed to generating sustainable added value. This is only possible if ecological, social as well as economic objectives are met. Our highest priorities are personal safety and environmentally sound processes and products.

    For more information, please visit our Sustainability section. 

    Sustainability
  • Clariant has implemented modern corporate governance structures to ensure accountability, responsibility and transparency throughout the Group and for its shareholders. Corporate governance reporting is in compliance with the guidelines of SIX Swiss Exchange and the Swiss Code of Best Practices in Corporate Governance.

    Corporate Governance

  • The way we do business is a key element for our reputation. Clariant wants to be perceived as a world-class performance company and by the same token, as a reliable and integral partner of our stakeholders all over the world. We are convinced that sustainable business success is closely linked to compliance with laws, regulations and ethical standards. Please visit the Clariant's Code of Conduct Webpage for additional information.



  • Coupon

     

    Maturity

     

    ISIN Number

    3.125   2011-2017   CH0130164418
    2.500   2012-2018   CH0188295239
    3.250   2012-2019   CH0181721629
    3.500   2012-2022   CH0188295312
    2.125   2014-2024   CH0253592759
  • The current market capitalization is calculated by multiplying the number of shares outstanding by the current share price. The share price is available on Clariant's webpage.

    Share Information
  • You can update your address data by contacting the bank maintaining your securities account. Alternatively you may submit your changes directly to the shareholder register - email: clariant@sharecomm.ch.
    avatar3

    Shareholder Register

    Contact Person

    Anfrage an Clariant

    Bitte geben Sie Ihre Kontaktinformationen ein, damit wir Ihr Anliegen bearbeiten können. Vielen Dank für Ihr Interesse.

    Ihr Name

     

    Ihre E-Mail-Adresse

    Ihre Position

    Ihr Unternehmen

    Land

    Telefon

  • The consolidated financial statements were based on the International Financial Reporting Standards (IFRS).
  • Clariant's current annual report can be downloaded as an Adobe pdf files. Alternatively, a printed copy may be ordered in the subscribe section.

    Publication Order Services

  • An AGM is primarily an event for shareholders, who may attend in person or be represented by proxy. Annual general meetings of large public companies are also of interest to the general public, and are regularly reported on in the media.

  • Each share held entitles you to one vote. The number of votes to which you are entitled depends on the number of shares registered under your shareholder number in the share register on the day of the AGM.


Datei herunterladen

Bitte geben Sie Ihre Kontaktdaten ein. Die Datei wird nach der Übermittlung Ihrer Daten sofort automatisch heruntergeladen. Dies ist nur für die erste Datei erforderlich, die Sie auf dieser Seite herunterladen. Vielen Dank für Ihr Verständnis.

Persönliche Informationen

Ihr Name*

 

Ihre E-Mail-Adresse*

Ihre Position

Ihr Unternehmen

Anfrage an Clariant

Bitte geben Sie Ihre Kontaktinformationen ein, damit wir Ihr Anliegen bearbeiten können. Vielen Dank für Ihr Interesse.

Ihr Name

 

Ihre E-Mail-Adresse

Ihre Position

Ihr Unternehmen

Land

Telefon

Disclaimer:
This information corresponds to the present state of our knowledge and is intended as a general description of our products and their possible applications. Clariant makes no warranties, express or implied, as to the information’s accuracy, adequacy, sufficiency or freedom from defect and assumes no liability in connection with any use of this information. Any user of this product is responsible for determining the suitability of Clariant’s products for its particular application. 


* Nothing included in this information waives any of Clariant’s General Terms and Conditions of Sale, which control unless it agrees otherwise in writing. Any existing intellectual/industrial property rights must be observed. Due to possible changes in our products and applicable national and international regulations and laws, the status of our products could change. Material Safety Data Sheets providing safety precautions, that should be observed when handling or storing Clariant products, are available upon request and are provided in compliance with applicable law. You should obtain and review the applicable Material Safety Data Sheet information before handling any of these products. For additional information, please contact Clariant.

* For sales to customers located within the United States and Canada the following applies in addition: No express or implied warranty is made of the merchantability, suitability, fitness for a particular purpose or otherwise of any product or service.

© Trademark of Clariant registered in many countries.
® 2013 Clariant International Ltd

Sie verlassen nun Clariant.com.

Über den von Ihnen aufgerufenen Link verlassen Sie in ungefähr 10 Sekunden die Seite Clariant.com. Wenn Sie diesen Vorgang aufhalten möchten, klicken Sie auf «Abbrechen».